---
document_datetime: 2025-12-09 13:17:01
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/inbrija-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: inbrija-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6969308
conversion_datetime: 2025-12-28 13:17:08.928479
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Inbrija

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number                                      | Scope                                                                              | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|---------------------------------------------------------|------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Marketing Authorisation Transfer - H / EMA/T/0000303317 | - Transfer of a marketing authorisation - transfer of marketing authorisation from | 16/10/2025                          | 21/11/2025                                  | SmPC, Labelling and              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                       | Acorda Therapeutics Ireland Limited to Merz Therapeutics GmbH                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |     | PL   |                   |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|-------------------|
| Variation type II /                   | This was an application for a group of variations. B.II.c.2 Change in test procedure for an excipient - B.II.c.2.d Other changes to a test procedure (including replacement or addition) - Accepted B.II.c.2 Change in test procedure for an excipient - B.II.c.2.d Other changes to a test procedure (including replacement or addition) - Accepted B.II.c.1 Change in the specification parameters and/or limits of an excipient - B.II.c.1.d Change outside the approved specifications limits range - Accepted | 09/10/2025 | N/A |      | EMA/VR/0000275645 |
| Variation type IB / EMA/VR/0000266340 | This was an application for a group of variations. B.II. FINISHED PRODUCT - B.II.z Other variation - Accepted B.II.e.7 Change in supplier of packaging components or devices (when mentioned in the dossier) - B.II.e.7.z Other changes - Accepted                                                                                                                                                                                                                                                                 | 04/06/2025 | N/A |      |                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|                            | A.5 Change in the name and/or address of manufacturer/importer of the finished product (including batch release or quality control testing sites) - A.5.b The activities for which the manufacturer/importer is responsible do not include batch release - Accepted   |             |
|----------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------|
| PSUR / EMA/PSUR/0000257892 | - -                                                                                                                                                                                                                                                                   | Maintenance |